5BE-25731-38027
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 146 / NY
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Dose 1 — Moderna
-
2021-02-28
Registered in v-safe
- 2021-02-28
- 2021-03-04
-
2021-03-05
Dose 2 — Moderna
-
2021-03-18
Survey response — day 7, dose 2MedDRA: Ophthalmic migraine — Feeling: GoodFree text: Last week (the week after the vaccine) I had two optical migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-21
- 2021-03-28
- 2021-04-02
- 2021-04-09
- 2021-09-03
- 2022-03-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Moderna | |
| 2 | 2021-03-05 | Moderna |
Free text
Release 5 — day 7, dose 2
Systemic reaction (other): Last week (the week after the vaccine) I had two optical migraines
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Ophthalmic migraine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release